Decades producing highly viscous sodium hyaluronate formulations (in excess of 100,000 cP) means we’ve developed expertise in unique products that are challenging to formulate, sterile filter, and aseptically fill.
We work closely with partners throughout their complete parenteral drug development program, ensuring that the final process is scalable and successfully transfers to a cGMP–compliant commercial manufacturing process.